Related Experiment Video

Updated: Jul 4, 2026

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity

David Taieb1, Julie Roignot, Frédéric André

  • 1INSERM U.624, Marseille cedex 9, France.

Cancer Research
|June 19, 2008
PubMed

Insights

The scaffold protein ArgBP2 is repressed in pancreatic cancer, promoting invasion and metastasis. Restoring ArgBP2 function could offer a new therapeutic strategy for this aggressive disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic cancer has a poor prognosis due to aggressive invasion, early metastasis, and ineffective therapies.
  • Current treatments targeting oncogenes and suppressors have yielded limited success in managing pancreatic cancer.

Purpose of the Study:

  • To investigate the role of the scaffold protein ArgBP2 in pancreatic cancer progression.
  • To elucidate the molecular mechanisms underlying ArgBP2's function in pancreatic cancer cell behavior.

Main Methods:

  • Utilized a pancreatic cancer cell line model to study ArgBP2 repression.
  • Performed in vitro analyses to assess ArgBP2's impact on cell adhesion, migration, proliferation, and apoptosis.
  • Identified novel ArgBP2-interacting proteins and analyzed its role in signaling pathways.

Main Results:

  • ArgBP2 expression is repressed during pancreatic oncogenic transformation.
  • Repression of ArgBP2 contributes to pancreatic cancer progression, specifically invasion and metastasis.
  • ArgBP2's anti-tumoral effects are primarily mediated through the regulation of cell adhesion and migration.
  • Identified a signaling complex involving WAVE/PTP-PEST/c-Abl regulated by ArgBP2.

Conclusions:

  • ArgBP2 repression is a novel mechanism driving pancreatic cancer invasion and metastasis.
  • The ArgBP2 signaling pathway presents a potential new therapeutic target for pancreatic cancer treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...